262 related articles for article (PubMed ID: 33188390)
21. The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.
Liu X; Li X; Li X; Li Z; Zhao D; Liu S; Zhang M; Zhang F; Zhu P; Chen J; Wei W; Lin B; Zhou Y; Chen J; Pang Y; Zhang L; Sun X; Yu Z; Jia Y; Wang J; Sun W; Chiu F; Pang L; Wang G
Clin Rheumatol; 2019 Mar; 38(3):657-664. PubMed ID: 30280368
[TBL] [Abstract][Full Text] [Related]
22. ESSPRI and other patient-reported indices in patients with primary Sjogren's syndrome during 100 consecutive outpatient visits at one rheumatological clinic.
Pertovaara M; Korpela M
Rheumatology (Oxford); 2014 May; 53(5):927-31. PubMed ID: 24464708
[TBL] [Abstract][Full Text] [Related]
23. Primary Sjögren's syndrome: Longitudinal real-world, observational data on health-related quality of life.
Tarn J; Lendrem D; McMeekin P; Lendrem C; Hargreaves B; Ng WF
J Intern Med; 2022 Jun; 291(6):849-855. PubMed ID: 35018685
[TBL] [Abstract][Full Text] [Related]
24. A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients.
Bai W; Yang F; Xu H; Wei W; Li H; Zhang L; Zhao Y; Shi X; Zhang Y; Zeng X; Leng X
Trials; 2023 Feb; 24(1):112. PubMed ID: 36793118
[TBL] [Abstract][Full Text] [Related]
25. Validation and adaptation to Spanish of the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI).
Posso-Osorio I; Nieto-Aristizábal I; Soto D; Ariza C; Urbano M; Cañas CA; Echeverri A; Castillo A; Tobón GJ
Reumatol Clin (Engl Ed); 2021; 17(7):388-391. PubMed ID: 34301381
[TBL] [Abstract][Full Text] [Related]
26. Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
Dörner T; Posch MG; Li Y; Petricoul O; Cabanski M; Milojevic JM; Kamphausen E; Valentin MA; Simonett C; Mooney L; Hüser A; Gram H; Wagner FD; Oliver SJ
Ann Rheum Dis; 2019 May; 78(5):641-647. PubMed ID: 30826774
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren's syndrome.
Choi BY; Oh HJ; Lee YJ; Song YW
Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S9-13. PubMed ID: 26315451
[TBL] [Abstract][Full Text] [Related]
28. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
[TBL] [Abstract][Full Text] [Related]
29. The efficacy and mechanism for action of iguratimod in primary Sjögren's syndrome patients.
Jiang W; Zhang L; Zhao Y; He X; Hu C; Liu Y
Int Ophthalmol; 2020 Nov; 40(11):3059-3065. PubMed ID: 32607949
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of iguratimod on patients with primary Sjögren's syndrome: a randomized, placebo-controlled clinical trial.
Shao Q; Wang S; Jiang H; Liu L
Scand J Rheumatol; 2021 Mar; 50(2):143-152. PubMed ID: 33118847
[No Abstract] [Full Text] [Related]
31. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
[TBL] [Abstract][Full Text] [Related]
32. Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.
Quartuccio L; Gandolfo S; Zabotti A; Zandonella Callegher S; Fabro C; De Vita S
Front Immunol; 2019; 10():1527. PubMed ID: 31354708
[No Abstract] [Full Text] [Related]
33. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
Bowman SJ; Fox R; Dörner T; Mariette X; Papas A; Grader-Beck T; Fisher BA; Barcelos F; De Vita S; Schulze-Koops H; Moots RJ; Junge G; Woznicki JN; Sopala MA; Luo WL; Hueber W
Lancet; 2022 Jan; 399(10320):161-171. PubMed ID: 34861168
[TBL] [Abstract][Full Text] [Related]
34. The role of orexin in fatigue and sleep quality in patients with primary Sjögren's syndrome.
Sandikci SC; Gultuna S; Ozisler C; Aydin FN
Z Rheumatol; 2024 Feb; 83(Suppl 1):242-247. PubMed ID: 38108866
[TBL] [Abstract][Full Text] [Related]
35. Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).
Meiners PM; Vissink A; Kroese FG; Spijkervet FK; Smitt-Kamminga NS; Abdulahad WH; Bulthuis-Kuiper J; Brouwer E; Arends S; Bootsma H
Ann Rheum Dis; 2014 Jul; 73(7):1393-6. PubMed ID: 24473674
[TBL] [Abstract][Full Text] [Related]
36. Do the European League Against Rheumatism (EULAR) Sjögren's syndrome outcome measures correlate with impaired quality of life, fatigue, anxiety and depression in primary Sjögren's syndrome?
Omma A; Tecer D; Kucuksahin O; Sandikci SC; Yildiz F; Erten S
Arch Med Sci; 2018 Jun; 14(4):830-837. PubMed ID: 30002701
[TBL] [Abstract][Full Text] [Related]
37. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
[TBL] [Abstract][Full Text] [Related]
38. Abdominal symptoms during Sjogren's syndrome: a pilot study.
Parreau S; Jacques J; Dumonteil S; Palat S; Geyl S; Gondran G; Bezanahary H; Liozon E; Azaïs J; Colombie S; Jauberteau MO; Loustaud-Ratti V; Ly KH; Fauchais AL
Adv Rheumatol; 2021 Jan; 61(1):5. PubMed ID: 33468262
[TBL] [Abstract][Full Text] [Related]
39. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T
Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950
[TBL] [Abstract][Full Text] [Related]
40. Fatigue in Saudi Patients with Primary Sjögren's Syndrome and Its Correlation with Disease Characteristics and Outcome Measures: A Cross-Sectional Study.
AlEnzi F; Alqahtani B; Alhamad EH; Daghestani M; Tashkandy Y; Othman N; Alshahrani K; Paramasivam MP; Halwani R; Omair MA
Open Access Rheumatol; 2020; 12():303-308. PubMed ID: 33293878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
